Studying the brain and supporting the mind
At MIT, senior Tarun Kamath has explored neuroscience and science policy, while helping his peers find ways to reduce stress.
At MIT, senior Tarun Kamath has explored neuroscience and science policy, while helping his peers find ways to reduce stress.
Inaugural AI Powered Drug Discovery and Manufacturing Conference drew pharmaceutical companies, government regulators, and pioneering drug researchers.
Comfortable, form-fitting garments could be used to remotely track patients’ health.
Manufacturability is key to producing a widely available, affordable vaccine.
Neurologist and researcher Diane Chan pitches in to help New England get through tough times.
An ad hoc team of engineers and doctors has developed a low-cost, open-source alternative, now ready for rapid production.
Team designs antibody-like receptor proteins that can bind to cytokines, as possible strategy for treating coronavirus and other infections.
MIT scientists Omar Abudayyeh and Jonathan Gootenberg explain the current state of Covid-19 testing, and how a CRISPR tool may help solve the supply problem.
Nuclear scientists and biomedical researchers team up to investigate whether treatment with gamma radiation could make N95 masks more reusable.
Physician and MIT economist provides insights into health care during the pandemic, and how electronic or “telehealth” service has become the new form of care.
Life science companies use Paradigm4’s unique database management system to uncover new insights into human health.
Chemical engineers have developed a way to protect transplanted drug-producing cells from immune system rejection.
MIT chemists are testing a protein fragment that may inhibit coronaviruses’ ability to enter human lung cells.
Clinical and design considerations will be published online; goal is to support rapid scale-up of device production to alleviate hospital shortages.
A variety of companies with MIT ties are working to address aspects of the Covid-19 pandemic.